Bottom line
Is WAINX a good fund? The bottom line
WAINX is the Investor Class share class of Wasatch Emerging India Fund, an actively managed emerging markets mutual fund from Wasatch.
Its expense ratio is 1.51% — about $151 a year on every $10,000 invested, more expensive than 86% of emerging markets funds we track.
It returned −5.5% over one year, +6.1% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $273 million in net assets and 32 holdings, its largest position is Max Healthcare Institute Ltd (9.4%) and the top 10 make up 56.6% of the portfolio.
What stands out
- 5-year return beat 80% of category peers
- No front-end sales load
What to watch
- Expensive for its category (1.51%)
- Concentrated: top 10 holdings are 56.6% of assets
Updated Nov 19, 2026
What WAINX invests in
The Funds investment objective is long-term growth of capital.
The Fund invests primarily in companies tied economically to India. Under normal market conditions, we will invest at least 80% of the Funds net assets (plus borrowings for investment purposes) in the equity securities, typically common stock, of companies of all market capitalizations tied economically to India. We will consider qualifying investments to be in companies that are listed on an Indian exchange, that have at least 50% of their assets in India, or that derive at least 50% of their revenues or profits from goods produced or sold, investments made, or services performed in India. India is considered an emerging market. Companies in the India region with economic ties to India may be located in India, Bangladesh, Pakistan and Sri Lanka. We use a process of quantitative screening followed by bottom up fundamental analysis to identify individual companies that we believe have…
From the fund's prospectus (filed Jan 28, 2026).
WAINX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| WAINX | −5.5% | +6.1% | +10.1% |
| Emerging Markets median | +27.8% | +3.0% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What WAINX costs
On a $10,000 investment, WAINX's 1.51% expense ratio costs about $151 a year. The prospectus estimates $1,802 in total costs over 10 years (assuming 5% annual returns). The median emerging markets fund charges 1.02%.
WAINX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Max Healthcare Institute Ltd | 9.40% |
| 2 | Cartrade Tech Ltd | 7.33% |
| 3 | Bajaj Finance Ltd | 6.41% |
| 4 | AU Small Finance Bank Ltd | 6.33% |
| 5 | Five-Star Business Finance Ltd | 5.66% |
| 6 | Aether Industries Ltd | 4.65% |
| 7 | Divi's Laboratories Ltd | 4.33% |
| 8 | Cholamandalam Investment and Finance Co Ltd | 4.18% |
| 9 | MakeMyTrip Ltd | 4.14% |
| 10 | Kfin Technologies Ltd | 4.14% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 56.6% of the fund. See all top 25 holdings and asset mix →